$2.67T
Total marketcap
$50.8B
Total volume
BTC 49.90%     ETH 17.07%
Dominance

Genovis AB (publ.) GENO.ST Stock

35.05 SEK {{ price }} 0.000000% {{change_pct}}%
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
2.29B SEK
LOW - HIGH [24H]
34.1 - 35.5 SEK
VOLUME [24H]
50.31K SEK
{{ volume }}
P/E Ratio
76.19
Earnings per share
0.46 SEK

Genovis AB (publ.) Price Chart

Genovis AB (publ.) GENO.ST Financial and Trading Overview

Genovis AB (publ.) stock price 35.05 SEK
Previous Close 52.9 SEK
Open 52.9 SEK
Bid 52.3 SEK x 0
Ask 52.6 SEK x 0
Day's Range 52.4 - 53.1 SEK
52 Week Range 31.15 - 71.8 SEK
Volume 9.38K SEK
Avg. Volume 75.51K SEK
Market Cap 3.44B SEK
Beta (5Y Monthly) 1.701149
PE Ratio (TTM) 76.08696
EPS (TTM) 0.46 SEK
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 82 SEK

GENO.ST Valuation Measures

Enterprise Value 3.44B SEK
Trailing P/E 76.08696
Forward P/E 12.209302
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 24.158983
Price/Book (mrq) 20.215633
Enterprise Value/Revenue 24.175
Enterprise Value/EBITDA 68.865

Trading Information

Genovis AB (publ.) Stock Price History

Beta (5Y Monthly) 1.701149
52-Week Change 14.00%
S&P500 52-Week Change 20.43%
52 Week High 71.8 SEK
52 Week Low 31.15 SEK
50-Day Moving Average 57.4 SEK
200-Day Moving Average 50.29 SEK

GENO.ST Share Statistics

Avg. Volume (3 month) 75.51K SEK
Avg. Daily Volume (10-Days) 73.1K SEK
Shares Outstanding 65.47M
Float 55.1M
Short Ratio N/A
% Held by Insiders 18.51%
% Held by Institutions 45.04%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:10

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 29.83%
Operating Margin (ttm) 33.07%
Gross Margin 88.94%
EBITDA Margin 35.10%

Management Effectiveness

Return on Assets (ttm) 17.12%
Return on Equity (ttm) 28.57%

Income Statement

Revenue (ttm) 142.26M SEK
Revenue Per Share (ttm) 2.17 SEK
Quarterly Revenue Growth (yoy) 118.79%
Gross Profit (ttm) 88.54M SEK
EBITDA 49.94M SEK
Net Income Avi to Common (ttm) 42.44M SEK
Diluted EPS (ttm) 0.69
Quarterly Earnings Growth (yoy) 253.69%

Balance Sheet

Total Cash (mrq) 115.4M SEK
Total Cash Per Share (mrq) 1.76 SEK
Total Debt (mrq) 6.4M SEK
Total Debt/Equity (mrq) 3.77 SEK
Current Ratio (mrq) 7.773
Book Value Per Share (mrq) 2.597

Cash Flow Statement

Operating Cash Flow (ttm) 47.05M SEK
Levered Free Cash Flow (ttm) 29.85M SEK

Profile of Genovis AB (publ.)

Country Sweden
State N/A
City Lund
Address Scheelevägen 2
ZIP 220 07
Phone 46 46 10 12 30
Website https://www.genovis.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 37

Genovis AB (publ.) designs, develops, and sells tools for development of new treatment methods and diagnostics for customers in the pharmaceutical and medical device industries. The company offers FabALACTICA, a cysteine protease that digests human IgG1; FabRICATOR, an enzyme that digests the hinge region of IgG; and FabRICATOR Z, an enzyme for the digestion of mouse IgG2a and IgG3, and generating a homogenous pool of F(ab')2 and Fc fragments. It also provides FabULOUS (SpeB), an enzyme for the digestion of IgG in the hinge region; GingisKHAN, a cysteine protease that digests human IgG1; and FabDELLO, a protease that digests human IgG1. In addition, the company offers GingisREX, a cysteine protease that specifically digests peptide bonds C-terminally; GlySERIAS, an enzyme that digests flexible glycine-rich fusion protein linkers; GlyCLICK, a conjugation technology for site-specific and quantitative conjugation of IgG; TransGLYCIT, a platform technology that enables site-specific human IgG glycan remodeling; OmniGLYZOR, a mixture of immobilized enzymes; PNGase F, a glycoamidase hydrolyzing the amide bond between the polypeptide asparagine and the innermost GlcNAc; and OpeRATOR, an O-glycan-specific protease. Further, it provides OglyZOR, an endoglycosidase; SialEXO, a sialidase product; FucosEXO, a mix of a-Fucosidases; GalactEXO, a ß-Galactosidase mix; GalNAcEXO, an a-N-Acetylgalactosaminidase; GlycOCATCH, an affinity resin for purification of mucin-type O-glycosylated proteins and peptides; GlycINATOR (EndoS2), an IgG-specific endoglycosidase; IgGZERO (EndoS), an IgG-specific endoglycosidase; Anti-FabRICATOR (Anti-IdeS), a goat polyclonal antibody; and Anti-FabRICATOR Z (Anti-IdeZ), a goat polyclonal antibody, as well as operates online store for its products. It serves pharmaceutical and biotech, contract research, and contract manufacturing companies in Sweden, Europe, North America, and Asia. Genovis AB (publ.) was founded in 1999 and is based in Lund, Sweden.

Q&A For Genovis AB (publ.) Stock

What is a current GENO.ST stock price?

Genovis AB (publ.) GENO.ST stock price today per share is 35.05 SEK.

How to purchase Genovis AB (publ.) stock?

You can buy GENO.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Genovis AB (publ.)?

The stock symbol or ticker of Genovis AB (publ.) is GENO.ST.

Which industry does the Genovis AB (publ.) company belong to?

The Genovis AB (publ.) industry is Biotechnology.

How many shares does Genovis AB (publ.) have in circulation?

The max supply of Genovis AB (publ.) shares is 65.47M.

What is Genovis AB (publ.) Price to Earnings Ratio (PE Ratio)?

Genovis AB (publ.) PE Ratio is 76.19565000 now.

What was Genovis AB (publ.) earnings per share over the trailing 12 months (TTM)?

Genovis AB (publ.) EPS is 0.46 SEK over the trailing 12 months.

Which sector does the Genovis AB (publ.) company belong to?

The Genovis AB (publ.) sector is Healthcare.

Genovis AB (publ.) GENO.ST included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
First North Sweden SEK PI FNSESEKPI 1878.6 SEK 183.37 USD
+0.16
1870.08 SEK 182.54 USD 1889.76 SEK 184.46 USD
First North Sweden EUR PI FNSEEURPI 1513.01 EUR 1653.92 USD
+0.67
1510.95 EUR 1651.67 USD 1533.41 EUR 1676.23 USD
First North 25 GI FN25GI 2268.44 EUR 2479.71 USD
-1.58
2266.11 EUR 2477.16 USD 2303.52 EUR 2518.06 USD
First North Health Care PI FN20PI 934.74 EUR 1021.8 USD
-1.95
933.5 EUR 1020.44 USD 953.35 EUR 1042.15 USD
First North All-Share SEK FIRSTNORTHSEK 126.34 SEK 12.33 USD
-0.9
126.23 SEK 12.32 USD 127.53 SEK 12.45 USD
First North All-Share DKK FIRSTNORTHDKK 101.04 DKK 14.82 USD
-1.33
100.96 DKK 14.8 USD 102.42 DKK 15.02 USD
First North Sweden SEK GI FNSESEKGI 2001.34 SEK 195.36 USD
-1.07
1999.37 SEK 195.16 USD 2020.41 SEK 197.22 USD
First North Sweden EUR GI FNSEEURGI 1616.97 EUR 1767.57 USD
-1.5
1615.38 EUR 1765.82 USD 1639.39 EUR 1792.08 USD
First North 25 FN25 2134.34 EUR 2333.12 USD
+0.5
2137.33 EUR 2336.39 USD 2172.61 EUR 2374.96 USD
First North Health Care GI FN20GI 939.04 EUR 1026.5 USD
-1.95
937.79 EUR 1025.13 USD 957.74 EUR 1046.94 USD
First North All-Share EUR FIRSTNORTHEUR 100.98 EUR 110.38 USD
-1.33
100.89 EUR 110.29 USD 102.35 EUR 111.88 USD